Bradycardia associated with remdesivir treatment in coronavirus disease 2019 patients: A propensity score-matched analysis
BS a , Salman Mohammed, MD Justin Bauzon, PhD Kavita Batra, BA Celica Cosme, BS a , Kim Inciong, MD Elli Tian, MD a , Fadi Azar, M d , Kevin Lee, MD d Nazanin Houshmand, MD d Uyen Pham, MD d Ariyon Schreiber, MD Aditi Singh
Medicine, doi:10.1097/md.0000000000044501
Remdesivir is an antiviral drug recommended for the treatment of COVID-19. The therapeutic benefits of remdesivir remain under investigation, with further literature emerging regarding its cardiac side-effect profile. The objective of this study was to investigate the association of remdesivir with bradycardia using a propensity score-matched analysis. Secondary outcomes included assessing in-patient mortality and hospital length of stay following remdesivir treatment for COVID-19. A single-institution retrospective study investigating treatment with and without remdesivir in 645 patients admitted for COVID-19 management was performed. Following treatment with remdesivir, patients were analyzed for episodes of bradycardia, defined in this study as 2 consecutive episodes of a heart rate <60 beats per minute. Matched cohorts were generated after controlling for potential confounders associated with remdesivir exposure. Subsequently, a propensity score-matched analysis was conducted to minimize selection bias and to account for the characteristics between the 2 comparison groups. In a sample of 645 COVID-19 patients, 58% were in the treatment group (Remdesivir+) and 42% were in the control group (Remdesivir-). 59% were males with a mean age of 57 ± 14.5 years. After propensity score matching, the remdesivir + group had a higher incidence of bradycardia (48.5% vs 30.7%, P = .028). The remdesivir + group was found to have a lower rate of in-patient mortality (1.0% vs 3.0% P < .001) and longer in-patient length of stay (13.7 vs 6.3 days, P < .001) compared to the remdesivir-group. Patients with COVID-19 had a greater prevalence of bradycardia following treatment with remdesivir. For these patients, remdesivir reduced in-patient mortality compared with untreated COVID-19 patients.
Author contributions Conceptualization: Salman Mohammed, Justin Bauzon
References
Ahmadi, Karimi, Abdollahi, Kabir, Modeling for prediction of mortality based on past medical history in hospitalized COVID-19 Patients: a secondary analysis, Can J Infect Dis Med Microbiol
Al-Jammali, Al-Zakhari, Sheets, Mahtani, Stefanishina et al., Bradyarrhythmia after remdesivir administration in SARS-CoV-2: a review of literature and meta-analysis of observational studies in epidemiology, Cardiol Res
Aleem, Kothadia, Remdesivir
Anderson, Bach, Baldwin, Hospital length of stay for patients with severe COVID-19: implications for Remdesivir's value, PharmacoEcon Open
Attena, Albani, Maraolo, Remdesivir-induced bradycardia in COVID-19: a single center prospective study, Circ Arrhythm Electrophysiol
Austin, Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies, Pharm Stat
Bauzon, Murphy, Wahi-Gururaj, Using macros in microsoft excel to facilitate cleaning of research data, J Community Hosp Intern Med Perspect
Beigel, Tomashek, Dodd, ACTT-1 Study Group Members. Remdesivir for the treatment of Covid-19 -final report, N Engl J Med
Bistrovic, Lucijanic, Remdesivir might induce changes in electrocardiogram beyond bradycardia in patients with coronavirus disease 2019-The pilot study, J Med Virol
Bistrovic, Manola, Lucijanic, Bradycardia during remdesivir treatment might be associated with improved survival in patients with COVID-19: a retrospective cohort study on 473 patients from a tertiary centre, Postgrad Med J
Brunetti, Poliseno, Bottalico, Safety and heart rate changes in Covid-19 patients treated with Remdesivir, Int J Infect Dis
Buczek, Azar, Bauzon, Batra, Murphy et al., The Data Error Criteria (DEC) for retrospective studies: development and preliminary application, J Investig Med
Capoferri, Osthoff, Egli, Stoeckle, Bassetti, Relative bradycardia in patients with COVID-19, Clin Microbiol Infect
Chalkias, Pantazopoulos, Papagiannakis, Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage, Toxicol Rep
Chokkalingam, Hayden, Goldman, Association of remdesivir treatment with mortality among hospitalized adults with COVID-19 in the United States, JAMA Netw Open
Cohen, Statistical Power Analysis for the Behavioral Sciences
Devlin, Skrobik, Gélinas, Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU, Crit Care Med
Diaz, Christensen, Pusch, Remdesivir and mortality in patients with COVID-19, Clin Infect Dis
Douedi, Mararenko, Alshami, COVID-19 induced bradyarrhythmia and relative bradycardia: an overview, J Arrhythm
Filtz, Carandina, Fasiello, Remdesivir-induced bradycardia in patients hospitalized with SARS-CoV2 infection: a possible vagally-mediated mechanism, Intern Emerg Med
Garrido, Kelley, Paris, Methods for constructing and assessing propensity scores, Health Serv Res
Grundeis, Ansems, Dahms, Remdesivir for the treatment of COVID-19, Cochrane Database Syst Rev
Gubitosa, Kakar, Gerula, Marked sinus bradycardia associated with remdesivir in COVID-19: a case and literature review, JACC Case Rep
Hafeez, Grossman, Sinus bradycardia
Haghjoo, Golipra, Kheirkhah, Effect of COVID-19 medications on corrected QT interval and induction of torsade de pointes: results of a multicenter national survey, Int J Clin Pract
Hajimoradi, Kashani, Dastan, Remdesivir associated sinus bradycardia in patients with COVID-19: a prospective longitudinal study, Front Pharmacol
Hung, Wang, Hung, Chen, An updated meta-analysis of pooled incidence of remdesivir-associated bradycardia, J Med Virol
Ishisaka, Aikawa, Malik, Kampaktsis, Briasoulis et al., Association of Remdesivir use with bradycardia: a systematic review and meta-analysis, J Med Virol
Izcovich, Siemieniuk, Bartoszko, Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomised trials, BMJ Open
Kumar, Arcuri, Chaudhuri, A novel study on SARS-COV-2 virus associated bradycardia as a predictor of mortality-retrospective multicenter analysis, Clin Cardiol
Leite, Practical Propensity Score Methods Using R
Liu, Pan, Yin, Li, Association of dyslipidemia with the severity and mortality of coronavirus disease 2019 (COVID-19): a meta-analysis, Virol J
Lovekirat, Boparai, Ceaser, 108: remdesivir and cardiac arrhythmia in COVID-19, Crit Care Med
Lucijanic, Bistrovic, Remdesivir-associated bradycardia might be a sign of good prognosis in COVID-19 patients, Clin Microbiol Infect
Mcmillan, Zureikat, Hogg, A propensity scorematched analysis of robotic vs open pancreatoduodenectomy on incidence of pancreatic fistula, JAMA Surg
Mozaffari, Chandak, Zhang, Remdesivir treatment in hospitalized patients with coronavirus disease 2019 (COVID-19): a comparative analysis of in-hospital all-cause mortality in a large multicenter observational cohort, Clin Infect Dis
Nabati, Parsaee, Potential cardiotoxic effects of remdesivir on cardiovascular system: a literature review, Cardiovasc Toxicol
Nagamine, Randhawa, Nishimura, Characteristics of bradyarrhythmia in patients with COVID-19: systematic scoping review, Pacing Clin Electrophysiol
Ohl, Miller, Lund, Association of remdesivir treatment with survival and length of hospital stay among US veterans hospitalized with COVID-19, JAMA Netw Open
Olender, Walunas, Martinez, Remdesivir versus standardof-care for severe coronavirus disease 2019 infection: an analysis of 28-day mortality, Open Forum Infect Dis
Pallotto, Suardi, Gabbuti, Esperti, Mecocci et al., Potential remdesivir-related transient bradycardia in patients with coronavirus disease 2019 (COVID-19), J Med Virol
Pantazopoulos, Mavrovounis, Dimeas, Remdesivirinduced bradycardia is not associated with worse outcome in patients with COVID-19: a retrospective analysis, Am J Cardiovasc Drugs
Saffar, Nabati, Saffar, Yazdani, Investigating the effects of remdesivir on corrected QT interval in patients with severe COVID-19 disease: a historical cohort study, BMC Cardiovasc Disord
Schreiber, Bauzon, Batra, Clinical characteristics and implications of bradycardia in COVID-19 patients treated with remdesivir: a single-center retrospective cohort study, Clin Drug Investig
Sekhon, Grieve, A matching method for improving covariate balance in cost-effectiveness analyses, Health Econ
Shaikh, Sarfaraz, Rahim, Hussain, Shah et al., Effect of Remdesivir on mortality and length of stay in hospitalized COVID-19 patients: a single center study, Pak J Med Sci
Steele, Gerlach, Elefritz, Sadaqat, Phelps, Incidence of bradycardia with the use of remdesivir for coronavirus disease of 2019 and risk factor analysis, Int J Crit Illn Inj Sci
Tajarernmuang, Trongtrakul, Chaiwong, Bradycardia and heart rate fluctuation are associated with a prolonged intensive care unit stay in patients with severe COVID-19, Medicina
Touafchia, Bagheri, Carrié, Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns, Clin Microbiol Infect
Umeh, Giberson, Kumar, Aseri, Barve, A multicenter retrospective analysis on the etiology of bradycardia in COVID-19 patients, Cureus
Uusalo, Valtonen, Järvisalo, Hemodynamic and respiratory effects of dexmedetomidine sedation in critically ill Covid-19 patients: a retrospective cohort study, Acta Anaesthesiol Scand
Valojerdi, Janani, A brief guide to propensity score analysis, Med J Islam Repub Iran
Veronese, Gennaro, Frallonardo, Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a propensity score matched analysis, Sci Rep
Zhang, Kim, Lonjon, Zhu, Balance diagnostics after propensity score matching, Ann. Transl. Med
DOI record:
{
"DOI": "10.1097/md.0000000000044501",
"ISSN": [
"0025-7974",
"1536-5964"
],
"URL": "http://dx.doi.org/10.1097/MD.0000000000044501",
"abstract": "<jats:p>Remdesivir is an antiviral drug recommended for the treatment of COVID-19. The therapeutic benefits of remdesivir remain under investigation, with further literature emerging regarding its cardiac side-effect profile. The objective of this study was to investigate the association of remdesivir with bradycardia using a propensity score-matched analysis. Secondary outcomes included assessing in-patient mortality and hospital length of stay following remdesivir treatment for COVID-19. A single-institution retrospective study investigating treatment with and without remdesivir in 645 patients admitted for COVID-19 management was performed. Following treatment with remdesivir, patients were analyzed for episodes of bradycardia, defined in this study as 2 consecutive episodes of a heart rate <60 beats per minute. Matched cohorts were generated after controlling for potential confounders associated with remdesivir exposure. Subsequently, a propensity score-matched analysis was conducted to minimize selection bias and to account for the characteristics between the 2 comparison groups. In a sample of 645 COVID-19 patients, 58% were in the treatment group (Remdesivir+) and 42% were in the control group (Remdesivir-). 59% were males with a mean age of 57 ± 14.5 years. After propensity score matching, the remdesivir + group had a higher incidence of bradycardia (48.5% vs 30.7%, <jats:italic toggle=\"yes\">P</jats:italic> = .028). The remdesivir + group was found to have a lower rate of in-patient mortality (1.0% vs 3.0% <jats:italic toggle=\"yes\">P</jats:italic> < .001) and longer in-patient length of stay (13.7 vs 6.3 days, <jats:italic toggle=\"yes\">P</jats:italic> < .001) compared to the remdesivir- group. Patients with COVID-19 had a greater prevalence of bradycardia following treatment with remdesivir. For these patients, remdesivir reduced in-patient mortality compared with untreated COVID-19 patients.</jats:p>",
"assertion": [
{
"group": {
"label": "Publication History",
"name": "publication_history"
},
"label": "Received",
"name": "received",
"value": "2024-10-21"
},
{
"group": {
"label": "Publication History",
"name": "publication_history"
},
"label": "Accepted",
"name": "accepted",
"value": "2025-08-26"
}
],
"author": [
{
"ORCID": "https://orcid.org/0000-0002-8881-5559",
"affiliation": [
{
"name": "Kirk Kerkorian School of Medicine at the University of Nevada, Las Vegas (UNLV), NV"
}
],
"authenticated-orcid": false,
"family": "Mohammed",
"given": "Salman",
"sequence": "first"
},
{
"affiliation": [
{
"name": "Kirk Kerkorian School of Medicine at the University of Nevada, Las Vegas (UNLV), NV"
},
{
"name": "Department of General Surgery, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, OH"
}
],
"family": "Bauzon",
"given": "Justin",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Medical Education and Office of Research, Kirk Kerkorian School of Medicine at UNLV, Las Vegas, NV"
}
],
"family": "Batra",
"given": "Kavita",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Kirk Kerkorian School of Medicine at the University of Nevada, Las Vegas (UNLV), NV"
}
],
"family": "Cosme",
"given": "Celica",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Kirk Kerkorian School of Medicine at the University of Nevada, Las Vegas (UNLV), NV"
}
],
"family": "Inciong",
"given": "Kim",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Kirk Kerkorian School of Medicine at the University of Nevada, Las Vegas (UNLV), NV"
}
],
"family": "Tian",
"given": "Elli",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Kirk Kerkorian School of Medicine at the University of Nevada, Las Vegas (UNLV), NV"
}
],
"family": "Azar",
"given": "Fadi",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Internal Medicine, Kirk Kerkorian School of Medicine at UNLV, Las Vegas, NV."
}
],
"family": "Lee",
"given": "Kevin",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Internal Medicine, Kirk Kerkorian School of Medicine at UNLV, Las Vegas, NV."
}
],
"family": "Houshmand",
"given": "Nazanin",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Internal Medicine, Kirk Kerkorian School of Medicine at UNLV, Las Vegas, NV."
}
],
"family": "Pham",
"given": "Uyen",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Internal Medicine, Kirk Kerkorian School of Medicine at UNLV, Las Vegas, NV."
}
],
"family": "Schreiber",
"given": "Ariyon",
"sequence": "additional"
},
{
"ORCID": "https://orcid.org/0000-0002-7247-2213",
"affiliation": [
{
"name": "Department of Internal Medicine, Kirk Kerkorian School of Medicine at UNLV, Las Vegas, NV."
}
],
"authenticated-orcid": false,
"family": "Singh",
"given": "Aditi",
"sequence": "additional"
}
],
"container-title": "Medicine",
"content-domain": {
"crossmark-restriction": true,
"domain": [
"lww.com",
"ovid.com"
]
},
"created": {
"date-parts": [
[
2025,
10,
6
]
],
"date-time": "2025-10-06T20:05:53Z",
"timestamp": 1759781153000
},
"deposited": {
"date-parts": [
[
2025,
10,
6
]
],
"date-time": "2025-10-06T20:05:58Z",
"timestamp": 1759781158000
},
"indexed": {
"date-parts": [
[
2025,
10,
7
]
],
"date-time": "2025-10-07T01:07:10Z",
"timestamp": 1759799230354,
"version": "build-2065373602"
},
"is-referenced-by-count": 0,
"issue": "40",
"issued": {
"date-parts": [
[
2025,
10,
3
]
]
},
"journal-issue": {
"issue": "40",
"published-print": {
"date-parts": [
[
2025
]
]
}
},
"language": "en",
"license": [
{
"URL": "http://creativecommons.org/licenses/by/4.0/",
"content-version": "unspecified",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2025,
10,
3
]
],
"date-time": "2025-10-03T00:00:00Z",
"timestamp": 1759449600000
}
}
],
"link": [
{
"URL": "https://journals.lww.com/10.1097/MD.0000000000044501",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "276",
"original-title": [],
"page": "e44501",
"prefix": "10.1097",
"published": {
"date-parts": [
[
2025,
10,
3
]
]
},
"published-print": {
"date-parts": [
[
2025,
10,
3
]
]
},
"publisher": "Ovid Technologies (Wolters Kluwer Health)",
"reference": [
{
"DOI": "10.1056/NEJMoa2007764",
"article-title": "Remdesivir for the treatment of Covid-19 – final report.",
"author": "Beigel",
"doi-asserted-by": "crossref",
"first-page": "1813",
"journal-title": "N Engl J Med",
"key": "R1-20251006",
"volume": "383",
"year": "2020"
},
{
"article-title": "Remdesivir for the treatment of COVID-19.",
"author": "Grundeis",
"first-page": "CD014962",
"journal-title": "Cochrane Database Syst Rev",
"key": "R3-20251006",
"volume": "1",
"year": "2023"
},
{
"DOI": "10.1016/S0140-6736(22)00519-0",
"article-title": "Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.",
"doi-asserted-by": "crossref",
"first-page": "1941",
"journal-title": "Lancet",
"key": "R4-20251006",
"volume": "399",
"year": "2022"
},
{
"DOI": "10.14740/cr1377",
"article-title": "Bradyarrhythmia after remdesivir administration in SARS-CoV-2: a review of literature and meta-analysis of observational studies in epidemiology.",
"author": "Al-Jammali",
"doi-asserted-by": "crossref",
"first-page": "135",
"journal-title": "Cardiol Res",
"key": "R5-20251006",
"volume": "13",
"year": "2022"
},
{
"DOI": "10.1007/s40261-022-01187-x",
"article-title": "Clinical characteristics and implications of bradycardia in COVID-19 patients treated with remdesivir: a single-center retrospective cohort study.",
"author": "Schreiber",
"doi-asserted-by": "crossref",
"first-page": "763",
"journal-title": "Clin Drug Investig",
"key": "R6-20251006",
"volume": "42",
"year": "2022"
},
{
"DOI": "10.1002/joa3.12578",
"article-title": "COVID-19 induced bradyarrhythmia and relative bradycardia: an overview.",
"author": "Douedi",
"doi-asserted-by": "crossref",
"first-page": "888",
"journal-title": "J Arrhythm",
"key": "R7-20251006",
"volume": "37",
"year": "2021"
},
{
"DOI": "10.1016/j.jaccas.2020.08.025",
"article-title": "Marked sinus bradycardia associated with remdesivir in COVID-19: a case and literature review.",
"author": "Gubitosa",
"doi-asserted-by": "crossref",
"first-page": "2260",
"journal-title": "JACC Case Rep",
"key": "R8-20251006",
"volume": "2",
"year": "2020"
},
{
"DOI": "10.1016/j.toxrep.2021.07.004",
"article-title": "Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage.",
"author": "Chalkias",
"doi-asserted-by": "crossref",
"first-page": "1394",
"journal-title": "Toxicol Rep",
"key": "R9-20251006",
"volume": "8",
"year": "2021"
},
{
"DOI": "10.1002/clc.23622",
"article-title": "A novel study on SARS-COV-2 virus associated bradycardia as a predictor of mortality-retrospective multicenter analysis.",
"author": "Kumar",
"doi-asserted-by": "crossref",
"first-page": "857",
"journal-title": "Clin Cardiol",
"key": "R10-20251006",
"volume": "44",
"year": "2021"
},
{
"DOI": "10.4103/ijciis.ijciis_57_24",
"article-title": "Incidence of bradycardia with the use of remdesivir for coronavirus disease of 2019 and risk factor analysis.",
"author": "Steele",
"doi-asserted-by": "crossref",
"first-page": "203",
"journal-title": "Int J Crit Illn Inj Sci",
"key": "R11-20251006",
"volume": "14",
"year": "2024"
},
{
"article-title": "A multicenter retrospective analysis on the etiology of bradycardia in COVID-19 patients.",
"author": "Umeh",
"first-page": "e21294",
"journal-title": "Cureus",
"key": "R12-20251006",
"volume": "14",
"year": "2022"
},
{
"DOI": "10.1161/CIRCEP.121.009811",
"article-title": "Remdesivir-induced bradycardia in COVID-19: a single center prospective study.",
"author": "Attena",
"doi-asserted-by": "crossref",
"first-page": "e009811",
"journal-title": "Circ Arrhythm Electrophysiol",
"key": "R13-20251006",
"volume": "14",
"year": "2021"
},
{
"DOI": "10.1002/jmv.27177",
"article-title": "Remdesivir might induce changes in electrocardiogram beyond bradycardia in patients with coronavirus disease 2019-The pilot study.",
"author": "Bistrovic",
"doi-asserted-by": "crossref",
"first-page": "5724",
"journal-title": "J Med Virol",
"key": "R16-20251006",
"volume": "93",
"year": "2021"
},
{
"DOI": "10.1136/bmjopen-2020-048502",
"article-title": "Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomised trials.",
"author": "Izcovich",
"doi-asserted-by": "crossref",
"first-page": "e048502",
"journal-title": "BMJ Open",
"key": "R17-20251006",
"volume": "12",
"year": "2022"
},
{
"DOI": "10.1186/s12985-021-01604-1",
"article-title": "Association of dyslipidemia with the severity and mortality of coronavirus disease 2019 (COVID-19): a meta-analysis.",
"author": "Liu",
"doi-asserted-by": "crossref",
"first-page": "157",
"journal-title": "Virol J",
"key": "R18-20251006",
"volume": "18",
"year": "2021"
},
{
"DOI": "10.1007/s41669-020-00243-6",
"article-title": "Hospital length of stay for patients with severe COVID-19: implications for Remdesivir’s value.",
"author": "Anderson",
"doi-asserted-by": "crossref",
"first-page": "129",
"journal-title": "PharmacoEcon Open",
"key": "R19-20251006",
"volume": "5",
"year": "2021"
},
{
"DOI": "10.1097/CCM.0000000000003299",
"article-title": "Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU.",
"author": "Devlin",
"doi-asserted-by": "crossref",
"first-page": "e825",
"journal-title": "Crit Care Med",
"key": "R20-20251006",
"volume": "46",
"year": "2018"
},
{
"DOI": "10.1111/aas.13970",
"article-title": "Hemodynamic and respiratory effects of dexmedetomidine sedation in critically ill Covid-19 patients: a retrospective cohort study.",
"author": "Uusalo",
"doi-asserted-by": "crossref",
"first-page": "1447",
"journal-title": "Acta Anaesthesiol Scand",
"key": "R21-20251006",
"volume": "65",
"year": "2021"
},
{
"DOI": "10.1080/20009666.2021.1954282",
"article-title": "Using macros in microsoft excel to facilitate cleaning of research data.",
"author": "Bauzon",
"doi-asserted-by": "crossref",
"first-page": "653",
"journal-title": "J Community Hosp Intern Med Perspect",
"key": "R22-20251006",
"volume": "11",
"year": "2021"
},
{
"DOI": "10.1177/10815589231151437",
"article-title": "The Data Error Criteria (DEC) for retrospective studies: development and preliminary application.",
"author": "Buczek",
"doi-asserted-by": "crossref",
"first-page": "448",
"journal-title": "J Investig Med",
"key": "R23-20251006",
"volume": "71",
"year": "2023"
},
{
"DOI": "10.1002/pst.433",
"article-title": "Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies.",
"author": "Austin",
"doi-asserted-by": "crossref",
"first-page": "150",
"journal-title": "Pharm Stat",
"key": "R25-20251006",
"volume": "10",
"year": "2011"
},
{
"DOI": "10.1093/cid/ciab875",
"article-title": "Remdesivir treatment in hospitalized patients with coronavirus disease 2019 (COVID-19): a comparative analysis of in-hospital all-cause mortality in a large multicenter observational cohort.",
"author": "Mozaffari",
"doi-asserted-by": "crossref",
"first-page": "e450",
"journal-title": "Clin Infect Dis",
"key": "R26-20251006",
"volume": "75",
"year": "2022"
},
{
"DOI": "10.1002/hec.1748",
"article-title": "A matching method for improving covariate balance in cost-effectiveness analyses.",
"author": "Sekhon",
"doi-asserted-by": "crossref",
"first-page": "695",
"journal-title": "Health Econ",
"key": "R27-20251006",
"volume": "21",
"year": "2012"
},
{
"DOI": "10.1111/1475-6773.12182",
"article-title": "Methods for constructing and assessing propensity scores.",
"author": "Garrido",
"doi-asserted-by": "crossref",
"first-page": "1701",
"journal-title": "Health Serv Res",
"key": "R29-20251006",
"volume": "49",
"year": "2014"
},
{
"DOI": "10.1001/jamasurg.2016.4755",
"article-title": "A propensity score-matched analysis of robotic vs open pancreatoduodenectomy on incidence of pancreatic fistula.",
"author": "McMillan",
"doi-asserted-by": "crossref",
"first-page": "327",
"journal-title": "JAMA Surg",
"key": "R30-20251006",
"volume": "152",
"year": "2017"
},
{
"DOI": "10.21037/atm.2018.12.10",
"article-title": "Balance diagnostics after propensity score matching.",
"author": "Zhang",
"doi-asserted-by": "crossref",
"first-page": "16",
"journal-title": "Ann. Transl. Med",
"key": "R31-20251006",
"volume": "7",
"year": "2019"
},
{
"DOI": "10.1016/j.cmi.2021.12.017",
"article-title": "Remdesivir-associated bradycardia might be a sign of good prognosis in COVID-19 patients.",
"author": "Lucijanic",
"doi-asserted-by": "crossref",
"first-page": "619",
"journal-title": "Clin Microbiol Infect",
"key": "R32-20251006",
"volume": "28",
"year": "2022"
},
{
"DOI": "10.3389/fphar.2022.1107198",
"article-title": "Remdesivir associated sinus bradycardia in patients with COVID-19: a prospective longitudinal study.",
"author": "Hajimoradi",
"doi-asserted-by": "crossref",
"first-page": "1107198",
"journal-title": "Front Pharmacol",
"key": "R33-20251006",
"volume": "13",
"year": "2023"
},
{
"DOI": "10.1007/s40256-022-00547-4",
"article-title": "Remdesivir-induced bradycardia is not associated with worse outcome in patients with COVID-19: a retrospective analysis.",
"author": "Pantazopoulos",
"doi-asserted-by": "crossref",
"first-page": "705",
"journal-title": "Am J Cardiovasc Drugs",
"key": "R34-20251006",
"volume": "22",
"year": "2022"
},
{
"DOI": "10.1136/postgradmedj-2021-141079",
"article-title": "Bradycardia during remdesivir treatment might be associated with improved survival in patients with COVID-19: a retrospective cohort study on 473 patients from a tertiary centre.",
"author": "Bistrovic",
"doi-asserted-by": "crossref",
"first-page": "501",
"journal-title": "Postgrad Med J",
"key": "R35-20251006",
"volume": "98",
"year": "2022"
},
{
"DOI": "10.1002/jmv.29584",
"article-title": "An updated meta-analysis of pooled incidence of remdesivir-associated bradycardia.",
"author": "Hung",
"doi-asserted-by": "crossref",
"first-page": "e29584",
"journal-title": "J Med Virol",
"key": "R36-20251006",
"volume": "96",
"year": "2024"
},
{
"DOI": "10.1002/jmv.29018",
"article-title": "Association of Remdesivir use with bradycardia: a systematic review and meta-analysis.",
"author": "Ishisaka",
"doi-asserted-by": "crossref",
"first-page": "e29018",
"journal-title": "J Med Virol",
"key": "R37-20251006",
"volume": "95",
"year": "2023"
},
{
"DOI": "10.1002/jmv.26898",
"article-title": "Potential remdesivir-related transient bradycardia in patients with coronavirus disease 2019 (COVID-19).",
"author": "Pallotto",
"doi-asserted-by": "crossref",
"first-page": "2631",
"journal-title": "J Med Virol",
"key": "R38-20251006",
"volume": "93",
"year": "2021"
},
{
"DOI": "10.1007/s11739-022-03168-6",
"article-title": "Remdesivir-induced bradycardia in patients hospitalized with SARS-CoV2 infection: a possible vagally-mediated mechanism [published online ahead of print, 2022 Dec 21].",
"author": "Filtz",
"doi-asserted-by": "crossref",
"first-page": "359",
"journal-title": "Intern Emerg Med",
"key": "R39-20251006",
"volume": "18",
"year": "2022"
},
{
"DOI": "10.1016/j.ijid.2021.09.036",
"article-title": "Safety and heart rate changes in Covid-19 patients treated with Remdesivir.",
"author": "Brunetti",
"doi-asserted-by": "crossref",
"first-page": "254",
"journal-title": "Int J Infect Dis",
"key": "R41-20251006",
"volume": "112",
"year": "2021"
},
{
"DOI": "10.1007/s12012-021-09703-9",
"article-title": "Potential cardiotoxic effects of remdesivir on cardiovascular system: a literature review.",
"author": "Nabati",
"doi-asserted-by": "crossref",
"first-page": "268",
"journal-title": "Cardiovasc Toxicol",
"key": "R42-20251006",
"volume": "22",
"year": "2022"
},
{
"DOI": "10.1016/j.cmi.2020.08.013",
"article-title": "Relative bradycardia in patients with COVID-19.",
"author": "Capoferri",
"doi-asserted-by": "crossref",
"first-page": "295",
"journal-title": "Clin Microbiol Infect",
"key": "R43-20251006",
"volume": "27",
"year": "2021"
},
{
"DOI": "10.1186/s12872-024-04380-2",
"article-title": "Investigating the effects of remdesivir on corrected QT interval in patients with severe COVID-19 disease: a historical cohort study.",
"author": "Saffar",
"doi-asserted-by": "crossref",
"first-page": "700",
"journal-title": "BMC Cardiovasc Disord",
"key": "R44-20251006",
"volume": "24",
"year": "2024"
},
{
"DOI": "10.1111/ijcp.14182",
"article-title": "Effect of COVID-19 medications on corrected QT interval and induction of torsade de pointes: results of a multicenter national survey.",
"author": "Haghjoo",
"doi-asserted-by": "crossref",
"first-page": "e14182",
"journal-title": "Int J Clin Pract",
"key": "R45-20251006",
"volume": "75",
"year": "2021"
},
{
"DOI": "10.1038/s41598-024-59957-w",
"article-title": "Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a propensity score matched analysis.",
"author": "Veronese",
"doi-asserted-by": "crossref",
"first-page": "9303",
"journal-title": "Sci Rep",
"key": "R46-20251006",
"volume": "14",
"year": "2024"
},
{
"DOI": "10.3390/medicina58070950",
"article-title": "Bradycardia and heart rate fluctuation are associated with a prolonged intensive care unit stay in patients with severe COVID-19.",
"author": "Tajarernmuang",
"doi-asserted-by": "crossref",
"first-page": "950",
"journal-title": "Medicina (Kaunas)",
"key": "R47-20251006",
"volume": "58",
"year": "2022"
},
{
"DOI": "10.1111/pace.14466",
"article-title": "Characteristics of bradyarrhythmia in patients with COVID-19: systematic scoping review.",
"author": "Nagamine",
"doi-asserted-by": "crossref",
"first-page": "556",
"journal-title": "Pacing Clin Electrophysiol",
"key": "R48-20251006",
"volume": "45",
"year": "2022"
},
{
"DOI": "10.1001/jamanetworkopen.2022.44505",
"article-title": "Association of remdesivir treatment with mortality among hospitalized adults with COVID-19 in the United States.",
"author": "Chokkalingam",
"doi-asserted-by": "crossref",
"first-page": "e2244505",
"journal-title": "JAMA Netw Open",
"key": "R49-20251006",
"volume": "5",
"year": "2022"
},
{
"DOI": "10.1093/ofid/ofab278",
"article-title": "Remdesivir versus standard-of-care for severe coronavirus disease 2019 infection: an analysis of 28-day mortality.",
"author": "Olender",
"doi-asserted-by": "crossref",
"first-page": "ofab278",
"journal-title": "Open Forum Infect Dis",
"key": "R50-20251006",
"volume": "8",
"year": "2021"
},
{
"DOI": "10.1001/jamanetworkopen.2021.14741",
"article-title": "Association of remdesivir treatment with survival and length of hospital stay among US veterans hospitalized with COVID-19.",
"author": "Ohl",
"doi-asserted-by": "crossref",
"first-page": "e2114741",
"journal-title": "JAMA Netw Open",
"key": "R51-20251006",
"volume": "4",
"year": "2021"
},
{
"DOI": "10.1093/cid/ciab698",
"article-title": "Remdesivir and mortality in patients with COVID-19.",
"author": "Diaz",
"doi-asserted-by": "crossref",
"first-page": "1812",
"journal-title": "Clin Infect Dis",
"key": "R52-20251006",
"volume": "74",
"year": "2022"
},
{
"DOI": "10.1016/j.cmi.2021.02.013",
"article-title": "Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns.",
"author": "Touafchia",
"doi-asserted-by": "crossref",
"first-page": "791.E5",
"journal-title": "Clin Microbiol Infect",
"key": "R53-20251006",
"volume": "25",
"year": "2021"
},
{
"DOI": "10.1097/01.ccm.0000806756.21865.b4",
"article-title": "108: remdesivir and cardiac arrhythmia in COVID-19.",
"author": "Lovekirat",
"doi-asserted-by": "crossref",
"first-page": "37",
"journal-title": "Crit Care Med",
"key": "R54-20251006",
"volume": "50",
"year": "2022"
},
{
"article-title": "A brief guide to propensity score analysis.",
"author": "Ebrahim Valojerdi",
"first-page": "122",
"journal-title": "Med J Islam Repub Iran",
"key": "R55-20251006",
"volume": "32",
"year": "2018"
},
{
"DOI": "10.1155/2024/3256108",
"article-title": "Modeling for prediction of mortality based on past medical history in hospitalized COVID-19 Patients: a secondary analysis.",
"author": "Ahmadi",
"doi-asserted-by": "crossref",
"first-page": "3256108",
"journal-title": "Can J Infect Dis Med Microbiol",
"key": "R56-20251006",
"volume": "2024",
"year": "2024"
},
{
"article-title": "Effect of Remdesivir on mortality and length of stay in hospitalized COVID-19 patients: a single center study.",
"author": "Shaikh",
"first-page": "405",
"journal-title": "Pak J Med Sci",
"key": "R57-20251006",
"volume": "38",
"year": "2022"
}
],
"reference-count": 51,
"references-count": 51,
"relation": {},
"resource": {
"primary": {
"URL": "https://journals.lww.com/10.1097/MD.0000000000044501"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "Bradycardia associated with remdesivir treatment in coronavirus disease 2019 patients: A propensity score-matched analysis",
"type": "journal-article",
"update-policy": "https://doi.org/10.1097/lww.0000000000001000",
"volume": "104"
}